PRO-LYMPHOCYTIC LEUKEMIA

Clinical trials for PRO-LYMPHOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new PRO-LYMPHOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for PRO-LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a safer dose after transplant help blood cancer patients recover with fewer infections?

Disease control Ongoing

This study is testing if using a lower dose of a standard drug (cyclophosphamide) given after a stem cell transplant can reduce serious infections in the first 100 days. The trial aims to see if this lower dose is just as good at preventing graft-versus-host disease, a common and…

Matched conditions: PRO-LYMPHOCYTIC LEUKEMIA

Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

PRO-LYMPHOCYTIC LEUKEMIA

Get alerted when new PRO-LYMPHOCYTIC LEUKEMIA trials appear

Could a safer dose after transplant help blood cancer patients recover with fewer infections?